NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

Key takeaways Cholesterol regulation and neuronal vulnerability: The study found that neurons in the locus coeruleus (LC)—a ...

Senolytics are considered an anti-aging medication, and they’re currently used to treat a range of health conditions. And new ...

Researchers have uncovered a crucial piece of the puzzle behind memory loss in Alzheimer’s disease. A team from the Institute ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...

In another experiment, the scientists treated the cells with NU-9 before adding the amyloid beta. NU-9 reduced the amount of ...

Alzheimer’s disease is one of the most well-known and widespread forms of dementia, affecting millions of people around the ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

Opinion: McDermott, Will & Emery's Byron Kalogerou and Meredith Cullen Schwartz say demand in the anti-obesity market and new ...

Researchers from National Taiwan University and collaborators have developed a novel way to observe and monitor carbon ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.